PL1853248T3 - Zastosowanie soli, addycyjnych i kompleksowych związków kwasu guanidynooctowego - Google Patents

Zastosowanie soli, addycyjnych i kompleksowych związków kwasu guanidynooctowego

Info

Publication number
PL1853248T3
PL1853248T3 PL06707381T PL06707381T PL1853248T3 PL 1853248 T3 PL1853248 T3 PL 1853248T3 PL 06707381 T PL06707381 T PL 06707381T PL 06707381 T PL06707381 T PL 06707381T PL 1853248 T3 PL1853248 T3 PL 1853248T3
Authority
PL
Poland
Prior art keywords
acid
salts
compounds
carnitine
complex compounds
Prior art date
Application number
PL06707381T
Other languages
English (en)
Polish (pl)
Inventor
Thomas Gastner
Hans-Peter Krimmer
Original Assignee
Alzchem Trostberg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alzchem Trostberg Gmbh filed Critical Alzchem Trostberg Gmbh
Publication of PL1853248T3 publication Critical patent/PL1853248T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06707381T 2005-03-04 2006-03-02 Zastosowanie soli, addycyjnych i kompleksowych związków kwasu guanidynooctowego PL1853248T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005009990A DE102005009990A1 (de) 2005-03-04 2005-03-04 Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
PCT/EP2006/001908 WO2006092298A1 (de) 2005-03-04 2006-03-02 Salze, anlagerungs- und komplexverbindungen der guanidinoessigsäure
EP06707381A EP1853248B1 (de) 2005-03-04 2006-03-02 Verwendung der SALZE, ANLAGERUNGS- UND KOMPLEXVERBINDUNGEN DER GUANIDINOESSIGSÄURE

Publications (1)

Publication Number Publication Date
PL1853248T3 true PL1853248T3 (pl) 2009-01-30

Family

ID=36129675

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06707381T PL1853248T3 (pl) 2005-03-04 2006-03-02 Zastosowanie soli, addycyjnych i kompleksowych związków kwasu guanidynooctowego

Country Status (17)

Country Link
US (1) US8153685B2 (cg-RX-API-DMAC7.html)
EP (1) EP1853248B1 (cg-RX-API-DMAC7.html)
JP (1) JP4928473B2 (cg-RX-API-DMAC7.html)
CN (1) CN101132786B (cg-RX-API-DMAC7.html)
AT (1) ATE412410T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006220005B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0609372B1 (cg-RX-API-DMAC7.html)
CA (1) CA2600890C (cg-RX-API-DMAC7.html)
DE (2) DE102005009990A1 (cg-RX-API-DMAC7.html)
DK (1) DK1853248T3 (cg-RX-API-DMAC7.html)
ES (1) ES2313616T3 (cg-RX-API-DMAC7.html)
PL (1) PL1853248T3 (cg-RX-API-DMAC7.html)
PT (1) PT1853248E (cg-RX-API-DMAC7.html)
RU (1) RU2402921C2 (cg-RX-API-DMAC7.html)
UA (1) UA97090C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006092298A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200706998B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014756A1 (de) * 2005-08-02 2007-02-08 Alzchem Trostberg Gmbh Flüssig-formulierung auf basis einer guanidinoessigsäure- komponente
DE102006009373A1 (de) * 2006-03-01 2007-09-06 Degussa Gmbh Fertigfutter für Haustiere
DE102007004781A1 (de) 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
US7874536B2 (en) * 2008-09-26 2011-01-25 Groover David O Angle ceiling hanger or bracket
RU2012132481A (ru) 2009-12-29 2014-02-10 Хилл`С Пет Ньютришн, Инк. Композиции для животных-компаньонов, включающие пируват, и способы их применения
CN101912044A (zh) * 2010-08-13 2010-12-15 青岛天通生物科技有限公司 促肌肉生成的组合物及其制备方法
CN104605161B (zh) * 2015-01-23 2018-02-27 长沙兴嘉生物工程股份有限公司 胍基乙酸配合物的制备方法及其应用
DE102019118898A1 (de) * 2019-07-12 2021-01-14 Alzchem Trostberg Gmbh Konzentrat zur Herstellung einer Tränklösung
DE102019120249A1 (de) * 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verwendung einer Zusammensetzung zur Reduzierung der Feuchtigkeit und des Stickstoffgehalts in Faeces von Geflügel
DE102019120246A1 (de) 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verfahren zur Fütterung von Geflügel
DE102019120244A1 (de) * 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verwendung einer Zusammensetzung zur Verminderung des Federverlustes von Vögeln
DE102019121526A1 (de) 2019-08-09 2021-02-11 Alzchem Trostberg Gmbh Konzentrat zur Herstellung von Tränklösungen (II)
DE102021100383A1 (de) * 2021-01-12 2022-07-14 Alzchem Trostberg Gmbh Verwendung eines Futtermitteladditives in proteinarmen Futter für Geflügel
DE102021126581A1 (de) 2021-10-13 2023-04-13 Alzchem Trostberg Gmbh Verwendung eines Futtermitteladditives in energiearmen Futter für Schweine
CN114751845B (zh) * 2022-06-13 2022-09-20 北京君德同创生物技术股份有限公司 一种易溶的胍基乙酸络合物的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
JPS61231996A (ja) * 1985-04-04 1986-10-16 Kikkoman Corp グアニジノ酢酸分解酵素の安定化法
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
JPH09202710A (ja) * 1995-11-20 1997-08-05 Kao Corp しわ改善剤
US5939078A (en) * 1995-11-20 1999-08-17 Kao Corporation Wrinkle-care product
JP3708229B2 (ja) * 1996-07-04 2005-10-19 花王株式会社 毛髪処理剤組成物
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
US20050287204A1 (en) * 2002-06-19 2005-12-29 Hageman Robert J J Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
PT1758463E (pt) * 2004-06-09 2008-04-03 Alzchem Trostberg Gmbh Ácido guanidinoacético como aditivo para rações para animais

Also Published As

Publication number Publication date
PT1853248E (pt) 2009-02-09
UA97090C2 (ru) 2012-01-10
CA2600890C (en) 2014-07-15
ES2313616T3 (es) 2009-03-01
CA2600890A1 (en) 2006-09-08
EP1853248B1 (de) 2008-10-29
RU2007136761A (ru) 2009-04-10
US20080161387A1 (en) 2008-07-03
BRPI0609372B1 (pt) 2020-09-08
ZA200706998B (en) 2008-11-26
CN101132786B (zh) 2011-04-13
RU2402921C2 (ru) 2010-11-10
ATE412410T1 (de) 2008-11-15
EP1853248A1 (de) 2007-11-14
CN101132786A (zh) 2008-02-27
HK1104782A1 (zh) 2008-01-25
AU2006220005B2 (en) 2011-07-21
DE102005009990A1 (de) 2006-09-07
JP4928473B2 (ja) 2012-05-09
DK1853248T3 (da) 2009-02-16
BRPI0609372A2 (pt) 2010-03-30
JP2008531029A (ja) 2008-08-14
WO2006092298A1 (de) 2006-09-08
US8153685B2 (en) 2012-04-10
DE502006001941D1 (de) 2008-12-11
AU2006220005A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
ZA200706998B (en) Salts, addition compounds and complex compounds of guanidinoacetic acid
WO2011107653A3 (en) Use of levodopa, carbidopa and entacapone for treating parkinson's disease
EA200970287A1 (ru) Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
PH12013502027A1 (en) Nutritional compositions having alpha-hica and alpha-ketoglutarate
IL203448A (en) History of azabiphenylaminobenzoic acid for use in the treatment or prevention of a pathological condition or disease susceptible to reduction by dhodh inhibition and medicinal preparations containing them
NZ610911A (en) Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
EP3192506A3 (en) Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient
NZ597510A (en) NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
ZA201005615B (en) Pharmaceutical compositions of entacapone,levodopa and carbidopa with improved bioavailability
MX2007013623A (es) Preparacion externa para la piel.
CL2013003057A1 (es) Composicion farmaceutica de aerosol en forma de solución acuosa para nebulización que comprende iloprost, que proporciona una dosis unica eficaz aerolizada para inhalacion de bolo en un periodo de menos de 2 minutos; kit farmacéutio, util en el tratamiento de hipertension arterial pulmonar.
WO2008135661A3 (fr) Utilisation de la citrulline pour pour le traitement de pathologies liees a une augmentation de la carbonylation des protéines
SG162744A1 (en) Stable active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
WO2010072209A3 (de) Nahrungsergänzungsmittel auf der basis von pantothensäure
JP2010508249A5 (cg-RX-API-DMAC7.html)
TR200806646A2 (tr) Entakapon, levodopa ve karbidoba içeren farmasötik kombinasyonlar
WO2007134038A3 (en) Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
EP1747786A3 (en) Natural product in cream with anti-vitiligo therapeutic properties
MY160005A (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
WO2013093069A3 (fr) Composition hydratante
BR112013031496A2 (pt) composição de aminoácidos
MX2009011817A (es) Formulaciones de aminoacido n-halogenado que contienen acido alifatico.
WO2014006571A3 (en) Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof